Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Automated Strain Construction for Biosynthetic Pathway Screening in Yeast.
Astolfi MCT, Yoder SD, Delfa-Lalaguna M, Winegar PH, Holm SKF, Lei M, Zhao X, Tan SE, Louie R, Hillson NJ, Hudson GA, Keasling JD. Astolfi MCT, et al. Among authors: yoder sd. ACS Synth Biol. 2025 Oct 17;14(10):4143-4151. doi: 10.1021/acssynbio.5c00554. Epub 2025 Oct 8. ACS Synth Biol. 2025. PMID: 41063332 Free PMC article.
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy.
Meads MB, Zhao X, Noyes DR, Sudalagunta P, Achille A, Zhang C, Renatino Canevarolo R, Silva M, Magaletti D, DeAvila D, Toska S, Oates A, Lastorino D, Idiaquez DW, Song J, Sansil S, Yoder SJ, Grajales-Cruz AF, Blue BJ, Freeman CL, Kim J, Alsina M, Brayer J, Siqueira Silva A, Song X, Shain KH, Baz RC. Meads MB, et al. Among authors: yoder sj. Blood. 2025 Sep 22:blood.2025029921. doi: 10.1182/blood.2025029921. Online ahead of print. Blood. 2025. PMID: 40983035
Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma.
Colin-Leitzinger C, Lawson-Michod KA, Johnson CE, Vlasac IM, Yoder S, Mesa T, Roeber D, Huff C, Hildebrandt MAT, Haller K, Alberg AJ, Bandera EV, Bondy M, Cote ML, Hastert T, Peters ES, Terry PD, Lawson AB, Berchuck A, Fridley BL, Chern JY, Doherty JA, Marks JR, Schildkraut JM, Christensen BC, Salas LA, Peres LC. Colin-Leitzinger C, et al. Among authors: yoder s. Clin Epigenetics. 2025 Jul 30;17(1):134. doi: 10.1186/s13148-025-01942-9. Clin Epigenetics. 2025. PMID: 40734190 Free PMC article.
Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing.
Yu X, Jain MD, Menges MA, Cen L, Noble JD, Atkins R, Mohammad TJ, Bachmeier CA, Naderinezhad S, Reid K, Corallo S, Yoder SJ, Zhang C, Zhang L, Miranda JA, Shah B, Chavez JC, Hesterberg RS, Delgado LC, Savid-Frontera C, Rodriguez PC, Cleveland JL, Wang X, Davila ML, Locke FL. Yu X, et al. Among authors: yoder sj. J Immunother Cancer. 2025 Jul 28;13(7):e011807. doi: 10.1136/jitc-2025-011807. J Immunother Cancer. 2025. PMID: 40730421 Free PMC article.
Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant.
Elmariah H, Kim J, Gonzalez R, DiMaggio E, Sansil S, Yoder S, Mishra A, Faramand R, Perez L, Lazaryan A, Mirza AS, Khimani F, Liu H, Ochoa-Bayona JL, Nieder M, Perna F, Figura N, Robinson TJ, Nishihori T, Anasetti C, Pidala JA, Bejanyan N. Elmariah H, et al. Among authors: yoder s. Am J Hematol. 2025 Sep;100(9):1665-1669. doi: 10.1002/ajh.27738. Epub 2025 Jun 10. Am J Hematol. 2025. PMID: 40492500 No abstract available.
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy.
Wang C, Yu X, Teer JK, Yao J, Du D, Liu X, Thompson ZJ, Wang MH, Welsh EA, Memon D, Chan TA, Makarov V, Anadon CM, Saeed L, Boyle TA, Fang B, Koomen JM, Cox C, Landin AM, Yoder SJ, Kim S, Chen DT, Pilon-Thomas SA, Conejo-Garcia JR, Antonia SJ, Haura EB, Creelan BC. Wang C, et al. Among authors: yoder sj. Nat Cancer. 2025 May;6(5):801-819. doi: 10.1038/s43018-025-00946-x. Epub 2025 May 8. Nat Cancer. 2025. PMID: 40341231
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma.
Renatino Canevarolo R, Sudalagunta PR, Meads MB, Silva M, Zhao X, Magaletti D, Alugubelli RR, DeAvila G, Persi E, Maura F, Bell ET, Bishop RT, Cubitt CL, Sansil SS, Zhang W, Teer JK, Teng M, Yoder SJ, Siegel EM, Shah BD, Nishihori T, Hazlehurst LA, Lynch CC, Landgren O, Hampton O, Gatenby RA, Sullivan DM, Brayer JB, Dalton WS, Cleveland JL, Alsina M, Baz R, Shain KH, Silva AS. Renatino Canevarolo R, et al. Among authors: yoder sj. Res Sq [Preprint]. 2025 Apr 15:rs.3.rs-6306816. doi: 10.21203/rs.3.rs-6306816/v1. Res Sq. 2025. PMID: 40321765 Free PMC article. Preprint.
219 results